Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.50T | 13.37T | 13.14T | 12.16T | 11.94T | 11.90T | Gross Profit |
6.80T | 1.92T | 10.37T | 9.59T | 9.48T | 9.47T | EBIT |
1.94T | 1.92T | 1.83T | 1.77T | 1.67T | 1.56T | EBITDA |
3.56T | 3.74T | 3.41T | 3.33T | 3.20T | 3.07T | Net Income Common Stockholders |
1.18T | 1.28T | 1.21T | 1.18T | 916.18B | 855.31B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.29T | 982.87B | 892.57B | 923.00B | 977.46B | 1.07T | Total Assets |
18.94T | 29.60T | 25.31T | 23.86T | 22.97T | 23.01T | Total Debt |
4.51T | 10.71T | 9.15T | 8.21T | 8.37T | 4.75T | Net Debt |
3.60T | 9.73T | 8.36T | 7.37T | 7.44T | 3.72T | Total Liabilities |
9.17T | 18.71T | 15.96T | 14.84T | 14.76T | 11.55T | Stockholders Equity |
7.79T | 9.84T | 8.56T | 8.28T | 7.56T | 9.06T |
Cash Flow | Free Cash Flow | ||||
115.51B | 290.15B | 409.13B | 1.25T | 1.21T | 1.14T | Operating Cash Flow |
2.23T | 2.37T | 2.26T | 3.01T | 3.01T | 3.00T | Investing Cash Flow |
-2.13T | -1.99T | -1.74T | -1.70T | -1.42T | -1.85T | Financing Cash Flow |
-39.71B | -234.45B | -590.20B | -1.44T | -1.69T | -1.04T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $14.26B | 10.13 | 16.61% | 5.66% | -2.99% | -7.36% | |
71 Outperform | $23.36B | 9.13 | 4.31% | 7.43% | -24.84% | -74.77% | |
69 Neutral | $82.65B | 11.13 | 11.36% | 2.57% | -4.36% | -11.33% | |
67 Neutral | $45.00B | 28.97 | 7.78% | 3.37% | 3.15% | -63.12% | |
64 Neutral | $27.94B | ― | <0.01% | 4.83% | 1.18% | ― | |
63 Neutral | $5.49B | 4.86 | 23.27% | ― | -26.74% | ― | |
59 Neutral | $27.83B | 1.88 | -18.16% | 4.00% | 2.13% | -44.45% |